Kramer Robin has filed 62 insider transactions across 2 companies since January 2023.
Most recent transaction: a grant/award of 25640 shares of Armata Pharmaceuticals, Inc. ($ARMP) on March 09, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 9, 2026 | Armata Pharmaceuticals, Inc. | $ARMP | Kramer Robin | Director | A | Stock Options (Right to Buy) | 25640 | $0.00 | 25,640.0000 | 36,226,285 | 9999.99% | 0.07% |
| Feb. 13, 2026 | BIOGEN INC. | $BIIB | Kramer Robin | Chief Financial Officer | A | Restricted Stock Unit | 8450 | $0.00 | 8,450.0000 | 170,500,000 | 9999.99% | 0.00% |
| Feb. 6, 2026 | BIOGEN INC. | $BIIB | Kramer Robin | Chief Financial Officer | M | Common Stock | 789 | $0.00 | 8,800.7483 | 170,500,000 | 9.85% | 0.00% |
| Feb. 6, 2026 | BIOGEN INC. | $BIIB | Kramer Robin | Chief Financial Officer | M | Restricted Stock Unit | 3511 | $0.00 | 7,024.0000 | 170,500,000 | 33.33% | 0.00% |
| Feb. 6, 2026 | BIOGEN INC. | $BIIB | Kramer Robin | Chief Financial Officer | M | Restricted Stock Unit | 703 | $0.00 | 704.0000 | 170,500,000 | 49.96% | 0.00% |
| Feb. 6, 2026 | BIOGEN INC. | $BIIB | Kramer Robin | Chief Financial Officer | M | Restricted Stock Unit | 789 | $0.00 | 0.0000 | 170,500,000 | 100.00% | 0.00% |
| Feb. 6, 2026 | BIOGEN INC. | $BIIB | Kramer Robin | Chief Financial Officer | F | Common Stock | 1063 | $201.18 | 11,471.7483 | 170,500,000 | 8.48% | 0.00% |
| Feb. 6, 2026 | BIOGEN INC. | $BIIB | Kramer Robin | Chief Financial Officer | M | Common Stock | 3511 | $0.00 | 12,534.7483 | 170,500,000 | 38.91% | 0.00% |
| Feb. 6, 2026 | BIOGEN INC. | $BIIB | Kramer Robin | Chief Financial Officer | F | Common Stock | 207 | $201.18 | 9,023.7483 | 170,500,000 | 2.24% | 0.00% |
| Feb. 6, 2026 | BIOGEN INC. | $BIIB | Kramer Robin | Chief Financial Officer | M | Common Stock | 703 | $0.00 | 9,230.7483 | 170,500,000 | 8.24% | 0.00% |
| Feb. 6, 2026 | BIOGEN INC. | $BIIB | Kramer Robin | Chief Financial Officer | F | Common Stock | 273 | $201.18 | 8,527.7483 | 170,500,000 | 3.10% | 0.00% |
| Feb. 10, 2025 | BIOGEN INC. | $BIIB | Kramer Robin | Chief Accounting Officer | M | Restricted Stock Unit | 834 | $0.00 | 0.0000 | 169,500,000 | 100.00% | 0.00% |
| Feb. 10, 2025 | BIOGEN INC. | $BIIB | Kramer Robin | Chief Accounting Officer | M | Common Stock | 834 | $0.00 | 8,256.7483 | 169,500,000 | 11.24% | 0.00% |
| Feb. 10, 2025 | BIOGEN INC. | $BIIB | Kramer Robin | Chief Accounting Officer | F | Common Stock | 245 | $142.54 | 8,011.7483 | 169,500,000 | 2.97% | 0.00% |
| Feb. 7, 2025 | BIOGEN INC. | $BIIB | Kramer Robin | Chief Accounting Officer | F | Common Stock | 232 | $141.35 | 6,963.7483 | 169,500,000 | 3.22% | 0.00% |
| Feb. 7, 2025 | BIOGEN INC. | $BIIB | Kramer Robin | Chief Accounting Officer | M | Common Stock | 703 | $0.00 | 7,666.7483 | 169,500,000 | 10.10% | 0.00% |
| Feb. 7, 2025 | BIOGEN INC. | $BIIB | Kramer Robin | Chief Accounting Officer | F | Common Stock | 244 | $141.35 | 7,422.7483 | 169,500,000 | 3.18% | 0.00% |
| Feb. 7, 2025 | BIOGEN INC. | $BIIB | Kramer Robin | Chief Accounting Officer | M | Restricted Stock Unit | 788 | $0.00 | 789.0000 | 169,500,000 | 49.97% | 0.00% |
| Feb. 6, 2025 | BIOGEN INC. | $BIIB | Kramer Robin | Chief Accounting Officer | A | Restricted Stock Unit | 10535 | $0.00 | 10,535.0000 | 169,500,000 | 9999.99% | 0.01% |
| Feb. 7, 2025 | BIOGEN INC. | $BIIB | Kramer Robin | Chief Accounting Officer | M | Restricted Stock Unit | 703 | $0.00 | 1,407.0000 | 169,500,000 | 33.32% | 0.00% |
| Feb. 7, 2025 | BIOGEN INC. | $BIIB | Kramer Robin | Chief Accounting Officer | M | Common Stock | 788 | $0.00 | 7,195.7483 | 169,500,000 | 12.30% | 0.00% |
| Feb. 5, 2025 | Armata Pharmaceuticals, Inc. | $ARMP | Kramer Robin | Director | A | Stock Options (Right to Buy) | 54343 | $0.00 | 54,343.0000 | 59,059,971 | 9999.99% | 0.09% |
| Dec. 6, 2024 | BIOGEN INC. | $BIIB | Kramer Robin | Chief Accounting Officer | M | Restricted Stock Unit | 351 | $0.00 | 0.0000 | 169,500,000 | 100.00% | 0.00% |
| Dec. 6, 2024 | BIOGEN INC. | $BIIB | Kramer Robin | Chief Accounting Officer | M | Common Stock | 351 | $0.00 | 6,577.7483 | 169,500,000 | 5.64% | 0.00% |
| Dec. 6, 2024 | BIOGEN INC. | $BIIB | Kramer Robin | Chief Accounting Officer | F | Common Stock | 170 | $157.78 | 6,407.7483 | 169,500,000 | 2.58% | 0.00% |
| March 14, 2024 | Armata Pharmaceuticals, Inc. | $ARMP | Kramer Robin | Director | A | Stock Options (Right to Buy) | 39666 | $0.00 | 39,666.0000 | 36,075,555 | 9999.99% | 0.11% |
| March 14, 2024 | Armata Pharmaceuticals, Inc. | $ARMP | Kramer Robin | Director | A | Stock Options (Right to Buy) | 54343 | $0.00 | 94,009.0000 | 36,075,555 | 137.00% | 0.15% |
| Feb. 16, 2024 | BIOGEN INC. | $BIIB | Kramer Robin | Chief Accounting Officer | J | Restricted Stock Unit | 537 | $0.00 | 0.0000 | 168,700,000 | 100.00% | 0.00% |
| Feb. 16, 2024 | BIOGEN INC. | $BIIB | Kramer Robin | Chief Accounting Officer | M | Restricted Stock Unit | 431 | $0.00 | 537.0000 | 168,700,000 | 44.52% | 0.00% |
| Feb. 16, 2024 | BIOGEN INC. | $BIIB | Kramer Robin | Chief Accounting Officer | M | Performance Stock Unit | 914 | $0.00 | 0.0000 | 168,700,000 | 100.00% | 0.00% |
| Feb. 16, 2024 | BIOGEN INC. | $BIIB | Kramer Robin | Chief Accounting Officer | F | Common Stock | 127 | $219.08 | 6,226.7483 | 168,700,000 | 2.00% | 0.00% |
| Feb. 16, 2024 | BIOGEN INC. | $BIIB | Kramer Robin | Chief Accounting Officer | M | Common Stock | 431 | $0.00 | 6,353.7483 | 168,700,000 | 7.28% | 0.00% |
| Feb. 16, 2024 | BIOGEN INC. | $BIIB | Kramer Robin | Chief Accounting Officer | F | Common Stock | 269 | $219.08 | 5,922.7483 | 168,700,000 | 4.34% | 0.00% |
| Feb. 16, 2024 | BIOGEN INC. | $BIIB | Kramer Robin | Chief Accounting Officer | M | Common Stock | 914 | $0.00 | 6,191.7483 | 168,700,000 | 17.32% | 0.00% |
| Feb. 9, 2024 | BIOGEN INC. | $BIIB | Kramer Robin | Chief Accounting Officer | M | Restricted Stock Unit | 833 | $0.00 | 834.0000 | 168,700,000 | 49.97% | 0.00% |
| Feb. 9, 2024 | BIOGEN INC. | $BIIB | Kramer Robin | Chief Accounting Officer | F | Common Stock | 245 | $240.98 | 5,277.7483 | 168,700,000 | 4.44% | 0.00% |
| Feb. 9, 2024 | BIOGEN INC. | $BIIB | Kramer Robin | Chief Accounting Officer | M | Common Stock | 833 | $0.00 | 5,522.7483 | 168,700,000 | 17.76% | 0.00% |
| Feb. 8, 2024 | BIOGEN INC. | $BIIB | Kramer Robin | Chief Accounting Officer | M | Common Stock | 788 | $0.00 | 4,942.7483 | 168,700,000 | 18.97% | 0.00% |
| Feb. 8, 2024 | BIOGEN INC. | $BIIB | Kramer Robin | Chief Accounting Officer | F | Common Stock | 253 | $240.30 | 4,689.7483 | 168,700,000 | 5.12% | 0.00% |
| Feb. 8, 2024 | BIOGEN INC. | $BIIB | Kramer Robin | Chief Accounting Officer | M | Restricted Stock Unit | 788 | $0.00 | 1,577.0000 | 168,700,000 | 33.32% | 0.00% |
| Feb. 7, 2024 | BIOGEN INC. | $BIIB | Kramer Robin | Chief Accounting Officer | A | Restricted Stock Unit | 2110 | $0.00 | 2,110.0000 | 168,700,000 | 9999.99% | 0.00% |
| Jan. 29, 2024 | BIOGEN INC. | $BIIB | Kramer Robin | Chief Accounting Officer | A | Performance Stock Unit | 914 | $0.00 | 914.0000 | 168,700,000 | 9999.99% | 0.00% |
| Dec. 8, 2023 | BIOGEN INC. | $BIIB | Kramer Robin | Chief Accounting Officer | F | Common Stock | 170 | $239.29 | 4,154.7483 | 167,900,000 | 3.93% | 0.00% |
| Dec. 8, 2023 | BIOGEN INC. | $BIIB | Kramer Robin | Chief Accounting Officer | M | Restricted Stock Unit | 351 | $0.00 | 351.0000 | 167,900,000 | 50.00% | 0.00% |
| Dec. 8, 2023 | BIOGEN INC. | $BIIB | Kramer Robin | Chief Accounting Officer | M | Common Stock | 351 | $0.00 | 4,324.7483 | 167,900,000 | 8.83% | 0.00% |
| June 30, 2023 | BIOGEN INC. | $BIIB | Kramer Robin | Chief Accounting Officer | M | Common Stock | 252 | $0.00 | 4,095.7483 | 167,900,000 | 6.56% | 0.00% |
| June 30, 2023 | BIOGEN INC. | $BIIB | Kramer Robin | Chief Accounting Officer | F | Common Stock | 122 | $284.85 | 3,973.7483 | 167,900,000 | 2.98% | 0.00% |
| June 30, 2023 | BIOGEN INC. | $BIIB | Kramer Robin | Chief Accounting Officer | M | Restricted Stock Unit | 252 | $0.00 | 0.0000 | 167,900,000 | 100.00% | 0.00% |
| Feb. 17, 2023 | BIOGEN INC. | $BIIB | Kramer Robin | Chief Accounting Officer | F | Common Stock | 238 | $278.38 | 3,331.7483 | 167,900,000 | 6.67% | 0.00% |
| Feb. 17, 2023 | BIOGEN INC. | $BIIB | Kramer Robin | Chief Accounting Officer | M | Common Stock | 512 | $0.00 | 3,843.7483 | 167,900,000 | 15.37% | 0.00% |
| Feb. 17, 2023 | BIOGEN INC. | $BIIB | Kramer Robin | Chief Accounting Officer | J | Restricted Stock Unit | 454 | $0.00 | 968.0000 | 167,900,000 | 31.93% | 0.00% |
| Feb. 17, 2023 | BIOGEN INC. | $BIIB | Kramer Robin | Chief Accounting Officer | M | Restricted Stock Unit | 512 | $0.00 | 1,422.0000 | 167,900,000 | 26.47% | 0.00% |
| Feb. 10, 2023 | BIOGEN INC. | $BIIB | Kramer Robin | Chief Accounting Officer | F | Common Stock | 67 | $286.30 | 3,830.7483 | 167,900,000 | 1.72% | 0.00% |
| Feb. 10, 2023 | BIOGEN INC. | $BIIB | Kramer Robin | Chief Accounting Officer | J | Restricted Stock Unit | 278 | $0.00 | 0.0000 | 167,900,000 | 100.00% | 0.00% |
| Feb. 10, 2023 | BIOGEN INC. | $BIIB | Kramer Robin | Chief Accounting Officer | F | Common Stock | 262 | $286.30 | 3,669.7483 | 167,900,000 | 6.66% | 0.00% |
| Feb. 10, 2023 | BIOGEN INC. | $BIIB | Kramer Robin | Chief Accounting Officer | M | Common Stock | 833 | $0.00 | 3,931.7483 | 167,900,000 | 26.88% | 0.00% |
| Feb. 10, 2023 | BIOGEN INC. | $BIIB | Kramer Robin | Chief Accounting Officer | M | Common Stock | 228 | $0.00 | 3,897.7483 | 167,900,000 | 6.21% | 0.00% |
| Feb. 10, 2023 | BIOGEN INC. | $BIIB | Kramer Robin | Chief Accounting Officer | M | Restricted Stock Unit | 228 | $0.00 | 278.0000 | 167,900,000 | 45.06% | 0.00% |
| Feb. 10, 2023 | BIOGEN INC. | $BIIB | Kramer Robin | Chief Accounting Officer | M | Restricted Stock Unit | 833 | $0.00 | 1,667.0000 | 167,900,000 | 33.32% | 0.00% |
| Feb. 10, 2023 | BIOGEN INC. | $BIIB | Kramer Robin | Chief Accounting Officer | F | Common Stock | 261 | $286.30 | 3,569.7483 | 167,900,000 | 6.81% | 0.00% |
| Feb. 8, 2023 | BIOGEN INC. | $BIIB | Kramer Robin | Chief Accounting Officer | A | Restricted Stock Unit | 2365 | $0.00 | 2,365.0000 | 167,900,000 | 9999.99% | 0.00% |
| Jan. 25, 2023 | BIOGEN INC. | $BIIB | Kramer Robin | Chief Accounting Officer | A | Common Stock | 887 | $0.00 | 3,098.7483 | 167,900,000 | 40.10% | 0.00% |